semaglutide online india India's weight-loss jabs now within the reach of millions Novo Nordisk launched Ozempic in

Not only is there rising social popularity of the drug, Petrou said, but theres also wider FDA indications for use. Semaglutide was patented by the Danish pharmaceutical company Novo Nordisk in 2012 and has been available in the United States since the FDA approved it in 2017

Frequency Once weekly Instructions Inject under the skin of your stomach, thigh, or upper arm Titration Start at 2.5mg, with increases every 4 weeks up to maximum 15mg Side Effects Common Side Effects Most side effects are mild and improve as your body adjusts to the medication

Doubling up is not supported by any published research and is not recommended

it is the starting weekly dose, but not a recommended maintenance dosage for weight loss

Though not considered a common side effect, some people have noticed hair loss on tirzepatide, particularly Zepbound